Dr. Juan Sanchez-Ramos, PhD, MD – Medical Director
Professor of Neurology at the University of South Florida in Tampa where he holds the Helen Ellis Endowed Chair for Parkinson’s disease Research.
Thomas N. Chase, S.B., M.D.
Dr. Chase has 40 years experience in the discovery and clinical development of new drugs for CNS disease, first at the National Institutes of Health (NIH) and then as founding CEO of Hamilton Pharmaceuticals.
Kathleen Clarence-Smith MD, PhD
Internationally-recognized neurologist whose career has been dedicated to developing new pharmaceuticals and shepherding them from early stages onto the market.
Abraham Lieberman, MD
Medical Director Muhammad Ali Parkinson Center, Barrow Neurological Institute, St. Joseph’s Hospital and Medical Center, Phoenix AZ
James Schumacher, M.D.
Internationally known expert in the neurosurgical treatment of Parkinson’s disease and movement disorders. Co-D
Patrick J Madden
Dr. Madden is a board certified diplomat of the American Board of Psychiatry and Neurology in neurodegenerative diseases with a focus on Parkinson’s disease.